Agomab Therapeutics AGMB Ratios (2024-2025)

NASDAQ AGMB
$13.39 -0.04 (-0.30%)
As of: Aug 21, 2026 · 2:27 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Ratios Dec2024 Dec2025
Efficiency
Assets Average (Quarter) 199.72M
Invested Capital (Quarter) 17.02M20.21M
Leverage & Solvency
Debt Ratio (Quarter) 0.04
Valuation
Enterprise Value (Quarter) -183.22M-135.63M